Rocket


Overview
Financials
News + Filings

 
 

Peloton Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17
Revenues31.623.1
            Revenue growth36.8% 
Cost of goods sold37.127.8
Gross profit-5.5-4.7
            Gross margin-17.5%-20.6%
General and administrative5.54.7
EBIT-37.1-27.8
            EBIT margin-117.5%-120.6%
Pre-tax income-36.1-24.9
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-36.1-24.9
            Net margin-114.3%-108.0%
 
Diluted EPS($15.30)($11.89)
Shares outstanding (diluted)2.42.1
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy